Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| Izobologrammas analīze× | Mihaēla-Mentenes kinētika× | Populācijas farmakodinamiskā modelēšana× | |
|---|---|---|---|
| Nozare | Farmakoloģija | Farmakoloģija | Farmakoloģija |
| Saime | Process / pipeline | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 1926 | 1913 | 1992 |
| Autors≠ | Salvatore Loewe | Leonor Michaelis and Maud Menten | Lewis Sheiner and Stephen Roush |
| Tips≠ | synergy quantification | mechanistic model | dose-response modeling |
| Pirmavots≠ | Loewe, S. (1926). Die Mischtoxizität. Zeitschrift für Experimentelle Pathologie und Therapie, 24, 315-334. link ↗ | Michaelis, L., & Menten, M. L. (1913). Die Kinetik der Invertinwirkung. Biochemische Zeitschrift, 49, 333-369. link ↗ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ |
| Citi nosaukumi | isobol, combination index, synergy testing | MM kinetics, Michaelis constant, Vmax | PopPD, population PD, hierarchical PD modeling |
| Saistītās≠ | 3 | 2 | 3 |
| Kopsavilkums≠ | Isobologram analysis is a graphical and quantitative method for detecting and classifying drug interactions, developed by Salvatore Loewe in 1926. It uses dose-response data from two drugs applied individually and in combination to determine whether their interaction is additive, synergistic, or antagonistic. | Michaelis-Menten kinetics describes the rate of enzyme-catalyzed reactions as a function of substrate concentration. Developed by Leonor Michaelis and Maud Menten in 1913, this foundational framework models enzyme catalysis through the rapid-equilibrium approximation and enables prediction of drug metabolism rates in pharmacokinetics. | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. |
| ScholarGateDatu kopa ↗ |
|
|
|